Review question / Objective: This study systematically evaluated the clinical efficacy and safety of Kangai injection combined with radiotherapy and chemotherapy in the treatment of gynecological malignant tumors. The subjects of the study were patients with clinical diagnosis of ovarian cancer, cervical cancer, and endometrial cancer. The experimental group was given Kang'ai injection combined with radiotherapy and chemotherapy, while the control group was given conventional chemotherapy. The primary outcome was the overall clinical response rate. Secondary outcomes included quality of life, body mass, indicators of immune function, and adverse events. Information sources: Eight databases including CNKI, Wan fang Database, VIP Chinese Database, China Biomedical Literature Service System, EI, Springer, PubMed, The Cochrane Library were searched before May 2022.